Bifogade filer
PDF
Beskrivning
| Land | Finland |
|---|---|
| Lista | Spotlight |
| Sektor | Handel & varor |
| Industri | Detaljhandel |
Eevia Health Plc ("Eevia" or "the Company") has secured new sales orders totaling approximately EUR 50,000 (SEK 550,000) from customers in the United States, France, Germany, and Finland.
New sales orders received this week of KEUR 50 include:
- EUR 28,000 for Feno-Chaga™ Organic SKUs
- EUR 11,000 for Feno-Myrtillus® Organic SKUs
- EUR 11,000 for other high-strength polyphenol extracts
All ordered products are available in inventory, enabling immediate fulfilment and avoiding delays related to raw material procurement. These inventory-based sales also contribute to near-term cash flow improvements, supporting operational liquidity.
The orders reflect continued demand growth for Eevia's premium organic bioactive ingredients across strategic markets and further validate the Company's product positioning in the global nutraceutical sector.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses global health challenges with bioactive compounds sustainably extracted from renewable plant materials. It focuses on the gut and related health, including kidney and urinary health.
Eevia Health is a manufacturer of 100% organically certified plant extracts. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
As a pioneering company, Eevia is developing high-value food ingredients, blended solutions, and biomaterials that significantly benefit human health. Eevia Health operates a modern green-chemistry production facility in Finland with a short value chain and environmentally friendly carbon footprint. Eevia listed its shares at the Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.